文献速递浆细胞疾病

多发性骨髓瘤中异常Wnt信号传导:分子机制与靶向选择

Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options.
PubMed 文献 · Leukemia · 2019-02-15

本文综述多发性骨髓瘤(MM)中异常Wnt/β-catenin信号激活的分子机制。MM中Wnt通路核心组分突变罕见,激活主要由Wnt调控组分的遗传和表观遗传病变引起,使MM细胞对自分泌Wnt配体及骨髓微环境旁分泌Wnt敏感。异常Wnt信号既介导MM细胞增殖、迁移和耐药,又通过分泌Wnt拮抗剂损害成骨细胞分化而促进溶骨性病变。由于MM细胞中Wnt信号主要依赖配体,可被作用于通路上游的药物或抗体靶向。

要点

  • MM中Wnt通路核心组分突变罕见,异常激活主要由Wnt调控组分的遗传和表观遗传病变驱动。
  • Wnt调控病变包括CYLD缺失、WIF1/DKK1/DKK3/sFRP1/sFRP2/sFRP4/sFRP5启动子甲基化及BCL9、LGR4过表达。
  • Wnt信号在MM中发挥双重作用:介导肿瘤细胞增殖、迁移和耐药,并通过Wnt拮抗剂促进溶骨性病变。

核心结论

  • MM中异常Wnt信号主要由Wnt调控组分的遗传和表观遗传病变引起,而非通路核心组分突变。
  • 异常Wnt信号在MM发病中发挥双重作用:介导肿瘤细胞增殖、迁移和耐药,并通过Wnt拮抗剂损害成骨细胞分化而促进溶骨性病变。
  • 由于MM细胞中Wnt信号主要依赖配体,可被作用于通路上游的药物或抗体靶向。

研究设计与样本

  • 综述,总结MM中异常Wnt信号传导的分子机制及靶向策略。

主要发现

  • MM中Wnt通路核心组分突变罕见,但多数肿瘤显示Wnt通路活性异常。
  • Wnt激活由Wnt调控组分的遗传和表观遗传病变引起,包括CYLD缺失、WIF1、DKK1、DKK3、sFRP1、sFRP2、sFRP4、sFRP5启动子甲基化及BCL9和LGR4过表达。
  • Wnts和R-spondins与MM细胞表面syndecan-1(CD138)相互作用强烈促进MM中Wnt活性。
  • 异常经典Wnt信号介导MM细胞增殖、迁移和耐药,MM细胞分泌的Wnt拮抗剂通过损害成骨细胞分化促进溶骨性病变。

临床怎么用

  • 作者认为,由于MM细胞中Wnt信号主要依赖配体,可被干扰Wnt分泌、隔离Wnt或阻断Wnt(共)受体的上游药物/抗体靶向。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aberrant activation of Wnt/β-catenin signaling plays a central role in the pathogenesis of a wide variety of malignancies and is typically caused by mutations in core Wnt pathway components driving constitutive, ligand-independent signaling. In multiple myelomas (MMs), however, these pathway intrinsic mutations are rare despite the fact that most tumors display aberrant Wnt pathway activity. Recent studies indicate that this activation is caused by genetic and epigenetic lesions of Wnt regulatory components, sensitizing MM cells to autocrine Wnt ligands and paracrine Wnts emanating from the bone marrow niche. These include deletion of the tumor suppressor CYLD, promotor methylation of the Wnt antagonists WIF1, DKK1, DKK3, and sFRP1, sFRP2, sFRP4, sFRP5, as well as overexpression of the co-transcriptional activator BCL9 and the R-spondin receptor LGR4. Furthermore, Wnt activity in MM is strongly promoted by interaction of both Wnts and R-spondins with syndecan-1 (CD138) on the MM cell-surface. Functionally, aberrant canonical Wnt signaling plays a dual role in the pathogenesis of MM: (I) it mediates proliferation, migration, and drug resistance of MM cells; (II) MM cells secrete Wnt antagonists that contribute to the development of osteolytic lesions by impairing osteoblast differentiation. As discussed in this review, these insights into the causes and consequences of aberrant Wnt signaling in MM will help to guide the development of targeting strategies. Importantly, since Wnt signaling in MM cells is largely ligand dependent, it can be targeted by drugs/antibodies that act upstream in the pathway, interfering with Wnt secretion, sequestering Wnts, or blocking Wnt (co)receptors.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. van Andel H, Kocemba KA, Spaargaren M, et al. Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Leukemia. 2019. PMID: 30770859. doi:10.1038/s41375-019-0404-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。